RoosterBio Inc.’s cover photo
RoosterBio Inc.

RoosterBio Inc.

Biotechnology Research

Frederick, Maryland 10,390 followers

Accelerating hMSC & Exosome Product & Process Development to Fuel Rapid Implementation of Scalable Advanced Therapies

About us

RoosterBio accelerates human mesenchymal stem/stromal cell (hMSC) and exosome/extracellular vesicle (EV) product and process development to fuel the rapid implementation of scalable advanced therapies. Our high-quality hMSCs, bioprocess media, genetic engineering tools, and exosome production solutions are paired with expert bioprocessing knowledge to progress therapeutic developers from concept to first-in-human testing and commercial manufacturing at reduced cost and increased productivity. With optimized, scalable processes, Type II Drug Master Files, and cGMP products, we have enabled therapeutic programs to traverse their path to clinical translation in under one year. RoosterBio is driven by our client's success and creating a world where safe and effective advanced therapies are rapidly developed and widely available on a global scale.

Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
Frederick, Maryland
Type
Privately Held
Founded
2013
Specialties
Mesenchymal Stem/Stromal Cells, Bioprinting, Tissue Engineering, Cell Therapy, Regenerative Medicine, Biomedical Engineering, Bioprocessing, Process Development, Democratizing Cell Technologies, Exosomes, Extracellular Vesicles , Advanced Therapies, Biotechnology, Cell and Gene Therapy, Stem Cell Research, and Biomanufacturing

Locations

Employees at RoosterBio Inc.

Updates

Similar pages

Browse jobs

Funding

RoosterBio Inc. 8 total rounds

Last Round

Series unknown

US$ 12.0M

See more info on crunchbase